THE USE O THE ANTI-SALMONELLA SPECIFIC POLYCLONAL ANTIBODIES. IN IMMUNO-PROPHYLAXIS AND TREATMENT OF THE QUAIL SALMONELLOSIS by CRISTE, ADRIANA
Bulletin USAMV-CN. 63 - 64/2007  
 
 
THE USE O THE ANTI-SALMONELLA SPECIFIC POLYCLONAL ANTIBODIES. IN 
IMMUNO-PROPHYLAXIS AND TREATMENT OF THE QUAIL SALMONELLOSIS 
 
Criste Adriana 
 
University of Agricultural Sciences and Veterinary Medicine. Manastur str.. 3-5. 400372.  
Cluj-Napoca. România. email: acriste@usamvcluj.ro 
 
Key words: IgY. immuno-prophylaxis. salmonelosis treatment. Salmonella gallinarum 
 
Absract. The administration of increased doses of antibodies in groups experimentally infected with 
Salmonella gallinarum. in order to record the efficiency of their administration in salmonellosis prophylaxis was 
the aim of our research. When a low infection dose. 1x107 CFU Salmonella gallinarum. was used the 
administration of IgY polyclonal antibodies as immunoglobulin extract. or even yolk administration had a 
protective effect against germs invasion. This effect was not recorded when a 10 folds higher dose was 
administered (1x108 CFU). When the administration of IgY polyclonal antibodies as immunoglobulin extract or 
yolk was continued after artificial infection. we can observe in the both experiments decrease of infected eggs 
with Salmonella gallinarum comparatively with the control groups. The prophylactic and therapeutic effect of 
the administration of polyclonal antibodies is demonstrated.  
 
INTRODUCTION 
 
The administration of high antibody doses in experimentally Salmonella gallinarum 
infected groups. with the aim of recording the efficiency of their administration in the 
prophylaxis and treatment of the salmonellosis. was the aim of our study.  The use of the 
antibodies both as immunoglobulin extract and directly as yolk of the eggs from the poultry 
submitted to Salmonella gallinarum hyper-immunization protocol aimed to emphasize some 
biological properties of the vitellin antibodies.   
 
MATERIALS AND METHODS 
 
The antibody producing: laying hens submitted to a hyper – immunization protocol 
with Salmonella gallinarum 9R for 10 weeks. applied 4 times during this time interval. were 
used to produce anti - Salmonella polyclonal antibodies. The eggs from the immunized hens 
were collected for testing the prophylactic and therapeutic effect of the antibodies. at 42 days 
interval from the first immunization.   
The biological material used in experimental groups. Six experimental groups 
made of 10 Coturnix conturnix japonica individuals each. aged of 70 days. were formed to 
determine the prophylactic and therapeutic effect of administration of the anti-Salmonella 
specific antibodies. The groups were made of 8 females and 2 males. quails were sheltered in 
special cages. each group in one cage. and feeding was performed with concentrate forage.  
Because both prophylactic and therapeutic effects of the antibody administration were aimed. 
the 6 groups were divided in two experiments as follows:   
 
 
 
Experiment I II 
The infection 
dose 
108CFU 107CFU 
Groups I 
Control 1 
II 
The  
III 
Yolk 
IV 
Control 2 
V 
The  
VI 
Yolk  
immunoglobulin 
extract 
immunoglobulin extract antibody 
 
The biological material used as inoculate: The infection was performed with 
different doses in both experiments. 1 x 108 CFU in Ist experiment. and reduced doses 1 x 107 
CFU in IInd experiment. The administration of the Salmonella gallinarum suspension was 
performed per oral with 1 mL microbial suspension/poultry.   
The experimental protocol: After division by groups. the poultry parasites were 
removed with   Albendazol. From one week after parasite removing. and division by groups. 
the antibodies were administered. They were administered. per oral. 1 mL/poultry. for 28 
days. after previous isolation with water and ammonia sulfate. or directly by yolk 
administration. The poultry infection was performed with different Salmonella gallinarum 
infection doses. 1 x 108 CFU. and reduced infection dose 1 x 107 CFU. respectively. with the 
aim of identification of the prophylactic and therapeutic effect of administration of polyclonal 
antibodies.   
Faeces samples were harvested in day 0 of the experiment. before administration of 
the Salmonella gallinarum suspension. and after four days from the administration of the 
infection dose. for emphasizing the infection with Salmonella. The identification of the 
presence of the infection with Salmonella gallinarum was realized for revealing the 
prophylactic and therapeutic effect of the IgY antibodies. It was performed by analyzing the 
quail eggs experimentally infected. The presence of the Salmonella gallinarum germs on egg 
shell. yolk and albumen was recorded. 
After inoculate administration. the vitellin antibodies continue to be administered. for 
three weeks. daily. per oral. 1 mL/individual as immunoglobulin extract or yolk. function of 
experimental groups.   
 
RESULTS AND DISCUSSIONS 
 
The clinic evaluation of the quails after experimental infection  
The absence of salmonella was recorded in faces samples harvested in the beginning 
of the experiment (day 0). before the administration of the Salmonella gallinarum suspension. 
in all experimental groups.   
In experiment I. where the infection doses was of 1 x 108 CFU. after four days after 
the experimental infection (day 4). 1 x 106 CFU/g faeces were recorded. The oral infection 
determined diarrhea. decrease of laying percent. but no mortality was recorded.   
In experiment II. where the infection doses was of 1 x 107 CFU. after four days after 
the experimental infection (day 4). 1 x 103 CFU/mg faeces were recorded. The oral infection 
determined no specific clinical signs. the lying percent did not decrease and no mortality was 
recorded. 
The isolation of the Salmonella from eggs 
The samples prelevated from the egg surface. yolk and albumen before the 
administration of the Salmonella gallinarum suspension. were negative in all experimental 
groups. Salmonella was absent in all these groups. 
 
Table 1 
Level of Salmonella  contamination in quail eggs after experimental infection 
 
Trial  Group  No. eggs Salm % Shell % White % Yolk % Test 
L I 142 131 92.25 129 90.84 5 3.52 3 2.11  1 x 108 
L II 156 121 77.56 120 76.92 3 1.92 1 0.64 ns 
L III 150 132 88.00 129 86.00 3 2.0 0 0 ns 
L IV 153 58 37.90 58 37.90 3 1.96 1 0.65  
L V 135 20 14.81 19 14.07 0 0 1 0.74 ** 
1x107 
L VI 148 21 14.18 19 12.83 2 1.35 0 0 ** 
 
The following figure emphasizes the dynamics concerning the egg contamination 
beginning with the first experimental day up to the end of the experiment. in all three 
experimental groups. 
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Figure 1. The level of egg contamination recorded during 1st experiment  
 
A high infection level is recorded in all three groups even from the first experimental 
day. after the administration of the bacterial suspension. meaning 83.33% in control group. 
80.00% in group which received the immunoglobulin extract. and 85.71%. respectively. in 
group which received yolk. The tendency of increased contamination level in eggs was 
maintained during the following experimental days. After 11 days from the experimental 
infection. all examined eggs from the experimental groups were infected with Salmonella. 
Beginning with the 15th day. the level of the infection decreases in groups where antibodies 
were administered. especially. In the end of the experiment. 62.50% of the eggs harvested 
from these groups were infected with Salmonella. while in control group 81.25% were 
infected. Even differences between experimental groups and control group were recorded they 
are statistically not significant (p > 0.05). 
The level of Salmonella infection was around 20% in the first day after the 
administration of the bacterial suspension. increased during the next days up to 30.76% in the 
3rd day in group V. which received the immunoglobulin extract. and the same level 30.76%. 
respectively. but in the 5th day in group VI. The number of the infected eggs gradually 
decreased in both groups and beginning with the 17th experimental day no infected eggs were 
recorded in experimental groups. 
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Figure 2. The level of egg contamination during the 2nd experiment  
 
Concerning the control group. the tendency of increased egg contamination was 
maintained up to the 9th experimental day. when 64.28% of the eggs were infected.   
After 11 days from the experimental infection. the number of the eggs infected with 
Salmonella gradually decreased. reaching 6.25%. In experimental groups which received 
antibodies as immunoglobulin extract. or directly yolk statistically significant differences (p < 
0.01) were recorded compared to control group. 
The administration of the polyclonal antibodies containing high anti-Salmonella 
specific antibodies represents an alternative to the use of the antibiotics in salmonellosis 
prophylaxis and treatment. reducing the negative impact of the antibiotics use.   
 
CONCLUSIONS 
 
The anti-Salmonella antibodies have practical application and can be successfully used 
in immuno-diagnosis reactions. The use of IgY polyclonal antibodies as immunoglobulin 
extract or even in natural form (egg yolk) in quail groups experimentally infected with 
Salmonella gallinarum. when a lower infection dose was administered (1 x 107 CFU 
Salmonella gallinarum) had protection effect against germ invasion. The administration of 
these antibodies after the artificially infestation of these poultry. too. led to the reducing of the 
infected eggs. The aspects emphasize the prophylactic and therapeutic effects of the 
administration of the IgY specific antibodies. 
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